BioXcel Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: BioXcel Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: BioXcel Therapeutics Inc
Rating: 1.07233325
Author: Trendlyne DVM scores

about

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeli...

2.21 0.01 (0.45%)

72.65% Fall from 52W High

240.7K

XNAS Volume

XNAS 22 Oct, 2025 10:47 AM (EDT)

Not Eligible

Expensive Valuation

3.8 / 100

Technically Neutral

39.1 / 100

1Yr Price target upside is 796%

5 analysts

BioXcel Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

BioXcel Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeli...

72.65% Fall from 52W High

SWOT Analysis

BioXcel Therapeutics Inc Live Price Chart